跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 55,725 条关于
“steroid-refractory chronic GVHD”
全部
55,725
临床试验
47,040
药物
417
机构
69
资讯
8,199
去年
REACH3 Trial Update: Ruxolitinib Shows Promising Efficacy in Steroid-Refractory Chronic GVHD
去年
Ruxolitinib Shows Superior Efficacy in Steroid-Refractory Chronic GVHD with 38-Month Median Failure-Free Survival
去年
Experts Discuss Treatment Strategies and Challenges in Managing Chronic GVHD After Stem Cell Transplantation
去年
REACH3 Trial Update Reinforces Ruxolitinib's Efficacy in Chronic Graft-versus-Host Disease
11个月前
Xenopax Demonstrates Superior Efficacy in Steroid-Refractory Acute GVHD Treatment
去年
ECP Treatment Shows Promising Results for Steroid-Resistant Chronic GVHD Patients
去年
Chronic GVHD Treatment Evolution: Biomarker-Guided Therapy and Steroid-Free Approaches Show Promise
2个月前
GvHD Pipeline 2026: Cell-Based, Microbiome and Targeted Therapies Reshape Treatment Landscape
2年前
Ruxolitinib Shows Promise in Refractory Sclerotic Chronic Graft-versus-Host Disease
24年前
Early Antithymocyte Globulin Therapy Enhances Survival in Steroid-Resistant Acute GVHD Patients
第 1 页，共 820 页
上一页
下一页
